Gsk Income Statement (2009-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	9.14B	33.29B	9.65B	8.73B	9.23B	16.56B	8.45B	8.98B	10.32B	17.54B	9.34B	9.95B	10.41B	19.57B	9.47B	10.65B	11.53B	20.62B	10.29B	11.28B
Cost of Revenue (Quarter)	2.78B	4.53B	3.65B	2.74B	2.86B	11.21B	2.36B	2.42B	2.88B	10.63B	2.50B	2.68B	3.11B	11.61B	2.44B	2.89B	3.05B	11.99B	2.53B	3.04B
Gross Profit (Quarter)	6.36B	22.29B	6.00B	5.99B	6.37B	10.82B	6.09B	6.56B	7.44B	12.73B	6.84B	7.27B	7.30B	14.32B	7.03B	7.77B	8.49B	15.16B	7.76B	8.24B
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	-1.95B	-3.00B	-1.48B	-1.56B	-1.59B	-6.44B	-1.53B	-1.68B	-2.00B	-7.72B	-1.82B	-1.86B	-1.90B	-8.22B	-1.84B	-2.70B	-2.28B	-10.01B	-2.28B	-4.65B
Selling, General & Administrative (Quarter)	-2.31B	-9.53B	-2.43B	-2.60B	-2.42B	-9.82B	-2.60B	-2.84B	-2.91B	-11.65B	-2.65B	-3.11B	-4.94B	-14.14B	-2.61B	-2.85B	-3.02B	-12.09B	-2.86B	-2.95B
Restructuring Costs (Quarter)	0.40B	0.81B	0.47B
Other Operating Expenses (Quarter)	-0.34B	-0.49B	0.80B	-0.66B	-1.26B	0.89B	0.36B	0.35B	-0.46B	0.71B	-0.68B	-0.40B	-0.44B	-1.96B	-0.01B	0.16B	0.03B	-0.16B	0.21B	-0.27B
Operating Expenses (Quarter)	-3.87B	-11.72B	-3.45B	-4.17B	-4.01B	-16.26B	-4.14B	-4.52B	-4.90B	-19.37B	-4.47B	-4.98B	-6.83B	-22.35B	-4.45B	-5.55B	-5.30B	-22.10B	-5.14B	-7.60B
Operating Income (Quarter)	1.90B	3.35B	3.08B	1.36B	1.40B	3.96B	2.53B	2.68B	2.47B	5.24B	1.89B	2.08B	0.25B	4.03B	2.79B	2.70B	3.50B	5.64B	3.09B	0.65B
EBIT (Quarter)	1.90B	3.35B	3.08B	1.36B	1.40B	3.96B	2.53B	2.68B	2.47B	5.24B	1.89B	2.08B	0.25B	4.03B	2.79B	2.70B	3.50B	5.64B	3.09B	0.65B
Non-operating items
Non Operating Interest Expenses (Quarter)	-0.27B	-1.04B	-0.28B	-0.26B	-0.24B	-1.03B	-0.25B	-0.23B	-0.23B	-0.98B	-0.21B	-0.22B	-0.20B	-0.86B	-0.20B	-0.25B	-0.23B	-0.93B	-0.23B	-0.24B
Non Operating Investment Income (Quarter)		-0.05B		1.23B		3.69B	-0.00B	2.18B	-2.21B	0.00B
Interest & Investment Income (Quarter)	0.01B	0.01B	0.01B	0.03B	0.03B	0.03B	0.04B	0.04B	0.03B	0.08B	0.04B	0.03B	0.04B	0.07B	0.07B	0.07B	0.04B	0.14B	0.03B	0.08B
Non Operating Income (Quarter)	-0.26B	-0.25B	-0.26B				-0.21B
Net income details
EBT (Quarter)	1.64B	2.84B	2.81B	1.13B	1.19B	3.51B	2.32B	2.49B	2.27B	4.83B	1.72B	1.89B	0.08B	3.66B	2.66B	2.52B	3.31B	5.31B	2.89B	0.47B
Tax Provisions (Quarter)	-0.34B	0.16B	-0.43B	-0.19B	-0.27B	-0.83B	0.34B	-0.30B	-0.33B	-0.94B	0.35B	-0.24B	0.00B	-0.68B	-0.42B	-0.32B	-0.42B	-1.48B	-0.41B	0.27B
Profit After Tax (Quarter)	1.30B	2.90B	2.38B	0.94B	2.86B	2.95B	1.98B	2.18B	1.94B	4.19B	1.37B	2.13B	0.08B	3.06B	2.23B	2.84B	3.74B	4.55B	2.48B	0.21B
Equity Income (Quarter)		0.04B
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)	1.89B	3.77B	2.91B	1.23B	12.80B	18.32B	1.98B	2.18B	1.94B	6.59B	1.37B	1.65B	0.08B	3.79B	2.23B	2.20B	2.89B	8.37B	2.48B	0.74B
Income from Continuing Operations (Quarter)	1.98B	2.68B	3.24B	1.32B	1.47B	4.34B	1.98B	2.79B	2.59B	5.77B	1.37B	2.13B	0.08B	4.33B	3.08B	2.84B	3.74B	6.79B	3.30B	0.21B
Income from Discontinued Operations (Quarter)	0.40B	1.44B	0.41B	0.17B	11.86B	0.51B
Consolidated Net Income (Quarter)	0.58B	0.87B	0.53B	0.29B	11.88B	12.55B	1.98B	2.79B	2.59B	5.77B	1.37B	2.13B	0.08B	4.33B	3.08B	2.84B	3.74B	6.79B	3.30B	0.21B
Income towards Parent Company (Quarter)	1.61B	3.33B	2.42B	1.06B	12.75B	17.54B	1.81B	2.03B	1.85B	3.86B	1.33B	1.48B	-0.08B	2.85B	2.05B	1.93B	2.72B	4.08B	2.34B	0.58B
Net Income towards Common Stockholders (Quarter)	1.61B	3.33B	2.42B	1.06B	12.75B	17.54B	1.81B	2.03B	1.85B	3.86B	1.33B	1.48B	-0.08B	2.85B	2.05B	1.93B	2.72B	4.08B	2.34B	0.58B
Additional items
EPS (Basic) (Quarter)	0.40	0.83	0.60	0.26	3.19	4.36	0.45	0.50	0.46	0.95	0.33	0.36	-0.02	0.70	0.50	0.47	0.67	1.01	0.58	0.14
EPS (Diluted) (Quarter)	0.40	0.82	0.60	0.26	3.15	4.30	0.44	0.50	0.45	0.94	0.32	0.36	-0.02	0.69	0.49	0.46	0.66	0.99	0.57	0.14
Shares Outstanding (Quarter)	3.98B	4.00B	4.00B	4.00B	4.00B	4.03B	4.04B	4.04B	4.04B	4.05B	4.07B	4.07B	4.07B	4.08B	4.08B	4.08B	4.08B	4.05B	4.05B	4.05B
Shares Outstanding (Diluted) (Quarter)	4.03B	4.05B	4.05B	4.05B	4.05B	4.08B	4.08B	4.08B	4.08B	4.11B	4.11B	4.11B	4.11B	4.14B	4.14B	4.14B	4.14B	4.12B	4.12B	4.12B
Shares Outstanding (Entity) (Quarter)		88.00				88.00	89.00			89.00	89.00			90.00				89.00
EBITDA (Quarter)	1.90B	3.35B	3.08B	1.36B	1.40B	3.96B	2.53B	2.68B	2.47B	5.24B	1.89B	2.08B	0.25B	4.03B	2.79B	2.70B	3.50B	5.64B	3.09B	0.65B
Interest Expenses (Quarter)	-0.27B	-1.02B	-0.28B	-0.42B	-0.05B	-0.92B	-0.15B	-0.37B	-0.01B	-0.56B	-0.09B	-0.31B	-0.02B	-0.63B	-0.09B	-0.29B	-0.05B	-0.70B	-0.11B	-0.30B
Tax Rate (Quarter)	-20.64%	5.56%	-15.43%	-16.74%	-23.02%	-23.65%	14.47%	-12.18%	-14.35%	-19.41%	20.22%	-12.78%	1.56%	-18.46%	-15.94%	-12.77%	-12.70%	-27.83%	-14.23%	56.21%

Research Tools

Datasets

Plans

Developers

Gsk GSK Income Statement (2009-2026)

Research Tools

Datasets

Plans

Developers

Gsk GSK Income Statement (2009-2026)

Create an account

Sign In

Reset Password